日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

托法替尼在溃疡性结肠炎不同情况下的真实世界疗效:一项回顾性全球多中心合作研究

Resál, Tamás; Bacsur, Péter; Keresztes, Csilla; Bálint, Anita; Bor, Renáta; Fábián, Anna; Farkas, Bernadett; Katsanos, Kostas; Michalopoylos, George; Ribaldone, Davide Giuseppe; Attauabi, Mohamed; Zhao, Mirabella; Barak, Hadar Amir; Yanai, Henit; Bezzio, Cristina; Rispo, Antonio; Castiglione, Fabiana; Bar-Gil Shitrit, Ariella; Pugliese, Daniela; Armuzzi, Alessandro; Savarino, Edoardo Vincenzo; Kolar, Martin; Lukáš, Milan; Chashkova, Elena; Filip, Rafał; Rozieres, Aurore; Nancey, Stéphane; Krznarić, Željko; Schäfer, Eszter; Szamosi, Tamás; Sarlós, Patrícia; Franko, Matej; Drobne, David; Knyazev, Oleg V; Kagramanova, Anna V; Limdi, Jimmy; Wetwittayakhlang, Panu; Lakatos, Peter L; Maharshak, Nitsan; Bannon, Lian; Nyári, Tibor; Szepes, Zoltán; Farkas, Klaudia; Molnár, Tamás

Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

皮下注射英夫利昔单抗治疗难治性克罗恩病患者:一种可能的生物改良疗法?

Cerna, Karin; Duricova, Dana; Lukas, Martin; Kolar, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kostrejova, Marta; Jirsa, Jakub; Kastylova, Kristyna; Peterka, Stepan; Vojtechova, Gabriela; Lukas, Milan

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy

皮肤微生物群特征可区分炎症性肠病患者,并反映抗TNF治疗期间的皮肤不良反应。

Reiss, Zuzana; Rob, Filip; Kolar, Martin; Schierova, Dagmar; Kreisinger, Jakub; Jackova, Zuzana; Roubalova, Radka; Coufal, Stepan; Mihula, Martin; Thon, Tomas; Bajer, Lukas; Novakova, Michaela; Vasatko, Martin; Kostovcikova, Klara; Galanova, Natalie; Lukas, Milan; Kverka, Miloslav; Tresnak Hercogova, Jana; Tlaskalova-Hogenova, Helena; Jiraskova Zakostelska, Zuzana

Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study

乌司奴单抗治疗与炎症性肠病患者特异性抗菌反应、血清生物标志物和微生物群组成变化之间的关联:一项初步研究

Rob, Filip; Schierova, Dagmar; Stehlikova, Zuzana; Kreisinger, Jakub; Roubalova, Radka; Coufal, Stepan; Mihula, Martin; Jackova, Zuzana; Kverka, Miloslav; Thon, Tomas; Kostovcikova, Klara; Bajer, Lukas; Drastich, Pavel; Hercogova, Jana Tresnak; Novakova, Michaela; Kolar, Martin; Vasatko, Martin; Lukas, Milan; Tlaskalova-Hogenova, Helena; Jiraskova Zakostelska, Zuzana

Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.

抗TNF治疗期间IBD患者的粪便微生物组变化和特异性抗菌反应

Schierova Dagmar, Roubalova Radka, Kolar Martin, Stehlikova Zuzana, Rob Filip, Jackova Zuzana, Coufal Stepan, Thon Tomas, Mihula Martin, Modrak Martin, Kverka Miloslav, Bajer Lukas, Kostovcikova Klara, Drastich Pavel, Hercogova Jana, Novakova Michaela, Vasatko Martin, Lukas Milan, Tlaskalova-Hogenova Helena, Jiraskova Zakostelska Zuzana

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases

生物类似药:炎症性肠病的概念、现状及未来展望

Park, Sang Hyoung; Park, Jae Cheol; Lukas, Milan; Kolar, Martin; Loftus, Edward V

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye

丛集素封闭小鼠干眼症的眼表屏障

Aditi Bauskar, Wendy J Mack, Jerome Mauris, Pablo Argüeso, Martin Heur, Barbara A Nagel, Grant R Kolar, Martin E Gleave, Takahiro Nakamura, Shigeru Kinoshita, Janet Moradian-Oldak, Noorjahan Panjwani, Stephen C Pflugfelder, Mark R Wilson, M Elizabeth Fini, Shinwu Jeong